Dalteparin in Preventing DVT in Participants With Cancer

NCT00525057 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Bone Sarcoma
Femur Fracture
Lymphoma
Metastatic Neoplasm
Pathologic Fracture
Plasma Cell Myeloma
Soft Tissue Sarcoma

Interventions

DRUG: Dalteparin

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]